NCT05164601Completed
Prognosis of Treated Acute Coronary Syndrome Patients: a Multicenter Study
A Multicenter, Prospective Cohort Study Evaluating the Prognosis of Patients with Acute Coronary Syndrome
Source: ClinicalTrials.gov · Last updated 4 Feb 2025
Brief summary (registry, in English)
The MPCS-ACS Study (Multicenter Prospective Cohort Study on Acute Coronary Syndrome) is a comprehensive, forward-looking research project designed to evaluate the prognostic outcomes of patients diagnosed with acute coronary syndrome (ACS) who declined coronary artery bypass grafting (CABG) and underwent percutaneous coronary intervention (PCI) instead. Leveraging a multicenter approach, the study aims to collect data from a diverse patient population, thereby enhancing the generalizability and clinical relevance of its findings. Upon enrollment, detailed information is gathered, including demographic data, clinical history, and key biochemical markers. The study also documents the various medication regimens prescribed during hospitalization to assess their influence on patient outcomes. A key feature of MPCS-ACS is its rigorous follow-up protocol, which involves regularly monitoring patients after discharge to track recovery progress and the occurrence of any subsequent cardiovascular events. This methodical approach is designed to generate valuable insights into the long-term prognosis of ACS patients treated with PCI, ultimately contributing to the refinement of therapeutic strategies and improving the standard of care across all participating centers.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 22500 (actual)
- First submitted
- 7 Nov 2018
- Start date
- 1 Jun 2016
- Primary completion date
- 31 May 2021
- Lead sponsor
- Xiang Xie
- Diseases
- Coronary artery disease
- NCT number
- NCT05164601
What you commit to
- Study type: Observational
- Participants enrolled: 22500
- From 1 Jun 2016 to the primary completion date, 31 May 2021
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with rheumatic heart disease, valvular heart disease, or congenital heart disease.
- Patients with malignant tumors or hematologic diseases.
- Patients with severe liver or kidney dysfunction or pulmonary heart disease.
- Patients with a life expectancy of less than one year due to terminal illnesses such as advanced cancer or chronic kidney disease requiring dialysis.
- Patients whose health is severely impacted by acute infections.
Who the study is looking for
- Men and women aged between 18 and 79 years.
- Patients diagnosed with Acute Coronary Syndrome (ACS), including Unstable Angina (UA) and Acute Myocardial Infarction (AMI), based on typical clinical symptoms, changes in electrocardiographic (ECG) readings, and elevated cardiac biomarkers.
- Patients who underwent coronary angiography confirming coronary artery stenosis and opted for PCI treatment instead of coronary artery bypass grafting (CABG).
- Patients who are under long-term follow-up.
Age in the registry: 18 years to 79 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital of Xinjiang Medical University Coordinator of this site? Confirm its status | Ürümqi | China | Unknown status |
| The First Affiliated Hospital of Xinjiang Medicial University Coordinator of this site? Confirm its status | Ürümqi | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.